Vor Biopharma Inc (NASDAQ: VOR) kicked off on Monday, up 10.48% from the previous trading day, before settling in for the closing price of $12.41. Over the past 52 weeks, VOR has traded in a range of $2.62-$65.80.
During the last 5-year period, the sales drop of Healthcare Sector giant was -38.02%. While this was happening, its average annual earnings per share was recorded -233.86%. With a float of $19.37 million, this company’s outstanding shares have now reached $21.91 million.
Vor Biopharma Inc (VOR) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vor Biopharma Inc is 11.62%, while institutional ownership is 42.16%. The most recent insider transaction that took place on Oct 29 ’25, was worth 6,343,284. In this transaction Director of this company sold 251,518 shares at a rate of $25.22, taking the stock ownership to the 804,231 shares. Before that another transaction happened on Oct 28 ’25, when Company’s Director sold 124,311 for $27.42, making the entire transaction worth $3,408,230. This insider now owns 1,055,749 shares in total.
Vor Biopharma Inc (VOR) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -8.8 earnings per share (EPS), lower than consensus estimate (set at -6.13) by -2.67. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.99 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -233.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.54% during the next five years compared to -38.02% drop over the previous five years of trading.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Take a look at Vor Biopharma Inc’s (VOR) current performance indicators. Last quarter, stock had a quick ratio of 9.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -386.85, a number that is poised to hit -1.64 in the next quarter and is forecasted to reach -5.81 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Looking closely at Vor Biopharma Inc (NASDAQ: VOR), its last 5-days average volume was 2.21 million, which is a jump from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 51.45%.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 16.50%, which indicates a significant decrease from 66.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.78 in the past 14 days, which was lower than the 2.64 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.61, while its 200-day Moving Average is $22.49. However, in the short run, Vor Biopharma Inc’s stock first resistance to watch stands at $14.38. Second resistance stands at $15.06. The third major resistance level sits at $16.22. If the price goes on to break the first support level at $12.54, it is likely to go to the next support level at $11.38. Should the price break the second support level, the third support level stands at $10.70.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
The company with the Market Capitalisation of 300.39 million has total of 10,411K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -116,914 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -812,684 K.
